Enanta Pharmaceuticals (ENTA) Other financing activities (2014 - 2026)
Enanta Pharmaceuticals' Other financing activities came in at $305,000 for fiscal Q2 2026 (quarter ended Mar 31, 2026), up 140.2% from $127,000 a year earlier and up 214.4% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Other financing activities (2014 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Other financing activities was $277,000, down 5.8% from FY2024.
- Other financing activities carries a five-year compound annual growth rate of -28.7% (FY2020 to FY2025).
- Going back by fiscal year, Other financing activities was $294,000 in FY2024 (-99.9%), $200 million in FY2023, $1.23 million in FY2022 (+130.1%) and $534,000 in FY2021 (-64.4%).
- The fiscal Q2 2026 figure represents the highest quarterly Other financing activities since fiscal Q3 2023.
- Year-over-year, Other financing activities increased in two of the last five quarters, with growth averaging 15.3%.
- The fastest year-over-year change in Other financing activities over five years came in fiscal Q2 2023 (growth of 545.0%), and the weakest in fiscal Q2 2024 (a decline of 96.8%).
- Business Quant data shows ENTA's Other financing activities at $97,000 (Q1 2026), $10,000 (Q4 2025) and $3,000 (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Jun 30, 2023 | 196.27 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 451,000.00 |
| Dec 31, 2021 | 777,000.00 |
| Dec 31, 2020 | 534,000.00 |
| Mar 31, 2020 | 358,000.00 |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2018 | -1,000.00 |
| Sep 30, 2017 | 11,000.00 |
API Access
Enanta Pharmaceuticals Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();